Abstract
To investigate the toxicity profile, activity, and pharmacokinetics of a novel L-nucleoside analog, troxacitabine (BCH-4556), in patients with advanced leukemia.
| Original language | English (Ireland) |
|---|---|
| Number of pages | 10 |
| Journal | Journal Of Clinical Oncology |
| Volume | 19 |
| Issue number | 3 |
| Publication status | Published - 1 Feb 2001 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Authors (Note for portal: view the doc link for the full list of authors)
- Authors
- Giles FJ, Cortes JE, Baker SD, Thomas DA, O'Brien S, Smith TL, Beran M, Bivins C, Jolivet J, Kantarjian HM
Fingerprint
Dive into the research topics of 'Troxacitabine, a novel dioxolane nucleoside analog, has activity in patients with advanced leukemia.'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver